Literature DB >> 637055

Pseudomonas maltophilia pseudosepticemia.

J D Semel, G M Trenholme, A A Harris, J E Jupa, S Levin.   

Abstract

During a 17 month period, 25 hospitalized adult patients had blood cultures reported as positive for Pseudomonas maltophila. Review of the hospital records suggested that these were contaminants and that blood for coagulation studies and for cultures that were subsequently positive had been drawn simultaneously. The source of contamination appeared to be black-top evacuated collection tubes used for coagulation studies in adults. Cultures of the liquid anticoagulant tubes yielded a pure growth of greater than 10(5) colony forming units (CFU)/cc of Ps. maltophilia on blood agar. Mock trials demonstrated that following venipuncture by syringe, inoculation of contaminated black-top tubes prior to inoculation of blood culture bottles would yield false-positive blood cultures (pseudosepticemia). One patient being treated for streptococcal prosthetic valve endocarditis and having frequent coagulation studies with blood obtained via direct venipuncture into evacuated collection tubes was found to have superinfection of his prosthetic valve with Ps. maltophilia at autopsy. Prosthetic valve infection may have occurred after reflux of contaminated anticoagulant from an evacuated collection tube directly into the vein. Contaminated evacuated collection tubes are a potential source of confusion in the diagnosis of infection as well as a potential source of true infection.

Entities:  

Mesh:

Year:  1978        PMID: 637055     DOI: 10.1016/0002-9343(78)90219-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Mechanism of cross-contamination of blood culture bottles in outbreaks of pseudobacteremia associated with nonsterile blood collection tubes.

Authors:  M M McNeil; B J Davis; R L Anderson; W J Martone; S L Solomon
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

2.  Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia.

Authors:  Y Saino; F Kobayashi; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

Review 3.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  DNA restriction fragment length polymorphism differentiates crossed from independent infections in nosocomial Xanthomonas maltophilia bacteremia.

Authors:  E H Bingen; E Denamur; N Y Lambert-Zechovsky; A Bourdois; P Mariani-Kurkdjian; J P Cezard; J Navarro; J Elion
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

5.  Tracking laboratory contamination by using a Bacillus cereus pseudoepidemic as an example.

Authors:  R M Morrell; B L Wasilauskas
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

Review 6.  Infective endocarditis due to Stenotrophomonas (Xanthomonas) maltophilia.

Authors:  R G Munter; A M Yinnon; Y Schlesinger; C Hershko
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

7.  Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination.

Authors:  T P Felegie; V L Yu; L W Rumans; R B Yee
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

8.  Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital.

Authors:  A J Morrison; K K Hoffmann; R P Wenzel
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

9.  Ewingella americana: recurrent pseudobacteremia from a persistent environmental reservoir.

Authors:  M M McNeil; B J Davis; S L Solomon; R L Anderson; S T Shulman; S Gardner; K Kabat; W J Martone
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

Review 10.  Unusual nosocomial infections.

Authors:  H C Neu
Journal:  Dis Mon       Date:  1984-10       Impact factor: 3.800

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.